title: Pharmacokinetics and Pharmacodynamics of Dabigatran 75 mg b.i.d. in Patients With Severe Chronic Kidney Disease.
authors.forename: Judith
authors.initials: J
authors.lastname: Kooiman
authors.forename: Tom
authors.initials: T
authors.lastname: van der Hulle
authors.forename: Hugo
authors.initials: H
authors.lastname: Maas
authors.forename: Sabrina
authors.initials: S
authors.lastname: Wiebe
authors.forename: Stephan
authors.initials: S
authors.lastname: Formella
authors.forename: Andreas
authors.initials: A
authors.lastname: Clemens
authors.forename: Marjolijn
authors.initials: M
authors.lastname: van Buren
authors.forename: Martien
authors.initials: M
authors.lastname: Janssen
authors.forename: Ton J
authors.initials: TJ
authors.lastname: Rabelink
authors.forename: Menno V
authors.initials: MV
authors.lastname: Huisman
mesh_terms: D000368:Aged; D000991:Antithrombins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D000069604:Dabigatran / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D011446:Prospective Studies; D051436:Renal Insufficiency, Chronic / Q000378:metabolism*; D012720:Severity of Illness Index
chemical_list: D000991:Antithrombins; D000069604:Dabigatran